“There were 11 healthcare M&A deals worth more than $1bn in enterprise value last year,” says Chuck Adams, global head of Citi’s healthcare, consumer and retail group. “We advised on seven of them.” ...

AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...

Bestselling author and speaker Maja Kazazic releases Scale Up Blueprint™, a practical 7-block framework for resilient growth in business and leadership. Scaling isn’t about doing more — it’s about ...

The FDA ImportShield Program centralizes import review, increasing processing speed by 66% and volume capacity by 33%, while ...

The Verdict: Janux Therapeutics’s Benzinga Edge signal reveals a classic ‘High-Flyer’ setup. While the Momentum (1.4) ...

The company plans to begin enrolling the trial next quarter across eight US sites to test the vaccine as a monotherapy and in combination with Keytruda.

Janux will conduct preclinical studies of the undisclosed program targeting a validated solid tumor antigen expressed across several cancer types.

Morning! Today, we hear that Pfizer CEO Albert Bourla spoke plainly at a WSJ Davos event about his distaste for health secretary RFK Jr.’s vaccine policy, see CEPI and Merck fund a more scalable Ebola ...

With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. | The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT ...

By Bhanvi Satija LONDON, Jan 22 (Reuters) - Sweeping U.S. policy changes under Health Secretary Robert F. Kennedy Jr. are ...

After U.S. President Donald Trump took the stage at the World Economic Forum this week to tout the supposed success of his ...

Merck & Co unit MSD and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a $30 ...